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OBJECTIVES The aim of this study was to assess the prognostic value of a noninvasive measure of left
ventricular diastolic pressure (LVDP) early after acute myocardial infarction (MI).
BACKGROUND The early diastolic velocity of the mitral valve annulus (e) reflects the rate of myocardial
relaxation. When combined with measurement of the early transmitral flow velocity (E), the
resultant ratio (E/e) correlates well with mean LVDP. In particular, an E/e ratio 15 is an
excellent predictor of an elevated mean LVDP. We hypothesized that an E/e ratio 15
would predict poorer survival after acute MI.
METHODS Echocardiograms were obtained in 250 unselected patients 1.6 days after admission for MI.
Patients were followed for a median of 13 months. The end point was all-cause mortality.
RESULTS Seventy-three patients (29%) had an E/e 15. This was associated with excess mortality
(log-rank statistic 21.3, p  0.0001) and was the most powerful independent predictor of
survival (risk ratio 4.8, 95% confidence interval 2.1 to 10.8, p 0.0002). The addition of E/e
15 improved the prognostic utility of a model containing clinical variables and conventional
echocardiographic indexes of left ventricular systolic and diastolic function (p  0.001).
CONCLUSIONS E/e is a powerful predictor of survival after acute MI. An E/e ratio 15 is superior, in this
respect, to other clinical or echocardiographic features. Furthermore, it provides prognostic
information incremental to these parameters. (J Am Coll Cardiol 2004;43:360–7) © 2004
by the American College of Cardiology Foundation
Advanced left ventricular (LV) diastolic dysfunction pre-
dicts a poorer prognosis after acute myocardial infarction
(MI) (1–3). In particular, echocardiographic indexes of
elevated LV filling pressures are associated with adverse
remodeling, an increased incidence of heart failure, and
worse survival (1–4). The deceleration time (DT) of early
transmitral flow is the most extensively investigated echo-
cardiographic diastolic parameter and appears to be the
simplest and most powerful predictor of outcome (2–6).
However, the correlation between DT and LV filling
pressure (or pulmonary capillary wedge pressure [PCWP])
is relatively poor in patients with preserved systolic function
(7).
To more accurately identify patients with elevated LV
filling pressures, transmitral flow patterns and DT have
been combined with other indicators of diastolic function
(7–12). Of these, Doppler tissue imaging of mitral annulus
motion appears to be particularly useful (7,12). Mitral
annulus velocity reflects the rate of change in LV long-axis
dimension and volume. This, in turn, is related to myocar-
dial relaxation, so that impaired relaxation results in a
reduced early mitral annulus velocity (e). Unlike other
Doppler parameters of diastolic function, e velocity appears
to be relatively independent of preload, especially when the
rate of myocardial relaxation is decreased (13). In addition,
the ratio of early transmitral flow velocity (E) to early
diastolic septal mitral annulus velocity (E/e) (Fig. 1) has
recently been shown to be the most accurate noninvasive
predictor of elevated LV filling pressure (7). Therefore, we
hypothesized that elevated E/e would predict an adverse
outcome after acute MI. To test this hypothesis, we evalu-
ated the prognostic value of E/e in a large series of
unselected patients with acute MI and compared this with
other established clinical, systolic, and diastolic parameters.
METHODS
Patients. Between August 1999 and July 2001, 593 pa-
tients were treated for acute MI at St. Mary’s Hospital,
Rochester, Minnesota, and also had a clinically indicated
transthoracic echocardiogram during their index admission.
The study group consisted of all 250 patients from this
population whose echocardiographic examination included
both Doppler assessment of transmitral flow velocities and
Doppler tissue imaging of the medial mitral valve annulus.
Myocardial infarction was defined using the European
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guidelines (14). The study was approved by the Institutional
Review Board of the Mayo Clinic.
Echocardiography. Echocardiography was performed by
experienced sonographers and reported by staff cardiologists
with advanced training in echocardiography. All echocar-
diographic data used in the current study were recorded by
the reviewing cardiologist at the time the scan was per-
formed. Left ventricular systolic function was assessed
semi-quantitatively using a visually estimated ejection frac-
tion (EF) and wall motion score index (WMSI), calculated
using a standard 16-segment model and five-point scoring
system (1  normal) (15). Previous work at our institution
has validated both of these methods (7,16,17). Mitral
regurgitation was graded using color flow imaging, includ-
ing the proximal isovelocity surface area method in 23 cases
(9%) (18).
Mitral inflow was assessed in the apical four-chamber
view, using pulsed-wave Doppler echocardiography, with
the Doppler beam aligned parallel to the direction of flow
and the sample volume at the leaflet tips. From the mitral
inflow profile, the E- and A-wave peak velocities and DT
were measured (19). Patients were categorized on the basis
of their DT (2–6). In these analyses, DT 140 ms was
considered abnormally abbreviated (1–3,5).
Doppler tissue imaging of the mitral annulus was ob-
tained from the apical four-chamber view, using a 1- to
2-mm sample volume placed in the septal mitral valve
annulus. Previous data have confirmed the excellent repro-
ducibility in this measurement and have also demonstrated
an E/e ratio 15 to be the best Doppler predictor of an
elevated (12 mm Hg) mean left ventricular diastolic
pressure (mLVDP) (7). An increased E/e ratio was there-
fore prospectively defined as 15.
Baseline clinical data and patient follow-up. Baseline
clinical data were obtained by chart review. Follow-up was
performed between January and April 2002 by using mailed
questionnaires, telephone interviews, a review of medical
records, and the Social Security Agency Death Index. The
study end point was death from all causes.
Abbreviations and Acronyms
CI  confidence interval
DT  deceleration time
E/e  ratio of early transmitral flow velocity to early
diastolic mitral annulus velocity
EF  ejection fraction
LV  left ventricle/ventricular
MI  myocardial infarction
mLVDP  mean left ventricular diastolic pressure
PCWP  pulmonary capillary wedge pressure
RR  risk ratio
WMSI  wall motion score index
Figure 1. Transmitral Doppler (top) and tissue Doppler (bottom) imaging of the mitral annulus. The mitral E-wave velocity is 80 cm/s, and the early mitral
annulus e velocity is 8 cm/s, giving an E/e ratio of 10.
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Statistical analyses. Continuous data are expressed as the
mean value  SD and compared using the Mann-Whitney
U test, unless otherwise specified. Categorical data are
presented as absolute values and percentages and compared
using the Fisher exact test. Correlations were calculated
using the Spearman rho test, and independent predictors of
an elevated E/e ratio were identified by regression analyses.
Survival was plotted according to the Kaplan-Meier
method, and mortality rates were compared using the
log-rank test. Further estimations of risk were performed
using Cox proportional hazard models. Potential indepen-
dent predictors of outcome were identified by univariate
analyses. All univariate predictors were then entered in a
stepwise manner into a multivariable model of survival, with
entry and retention set at a significance level of 0.05.
Where appropriate, probability values take into account
multiple comparisons. SPSS version 9.0 (SPSS Inc., Chi-
cago, Illinois) was used for all analyses.
Table 1. Clinical Characteristics
Characteristic
All Patients
(n  250)
E/e <15
(n  177)
E/e >15
(n  73) p Value
Age (yrs) 68  13 65  13 75  10 0.001
Risk factors and medical history
Male gender 155 (62%) 120 (68%) 35 (48%) 0.004
Current smoker 57 (23%) 44 (25%) 13 (18%) 0.25
Diabetes 56 (22%) 30 (17%) 26 (36%) 0.002
Hypertension 142 (57%) 95 (54%) 47 (64%) 0.13
Hyperlipidemia 104 (42%) 70 (40%) 34 (47%) 0.33
Previous acute MI 50 (20%) 26 (15%) 24 (33%) 0.002
Previous revascularization 44 (18%) 27 (15%) 17 (23%) 0.15
Anterior MI 106 (42%) 77 (44%) 29 (40%) 0.67
ST-segment elevation MI 120 (48%) 90 (51%) 30 (41%) 0.71
Thrombolytic therapy 39 (16%) 31 (18%) 8 (11%) 0.25
In-hospital revascularization
PCI 160 (64%) 119 (67%) 41 (56%) 0.11
CABG 18 (7%) 9 (5%) 9 (12%) 0.06
Multivessel coronary disease* 117 (54%) 79 (50%) 38 (64%) 0.07
In-hospital therapy
Heparin 237 (95%) 170 (96%) 67 (92%) 0.21
Intravenous nitroglycerin 152 (61%) 109 (62%) 43 (59%) 0.78
Inotropic therapy 39 (16%) 23 (13%) 16 (22%) 0.09
IABP 20 (8%) 13 (7%) 7 (10%) 0.61
Killip class 2 on admission 103 (41%) 54 (31%) 49 (67%) 0.001
*Angiography was performed in 216 patients (86%): 157 patients with E/e 15 and 59 patients with E/e 15. Data are
expressed as the mean value  SD or number (percentage) of patients.
CABG  coronary artery bypass grafting; IABP  intra-aortic balloon pump; MI  myocardial infarction; PCI 
percutaneous coronary intervention.
Table 2. Echocardiographic Characteristics
Characteristic
All Patients
(n  250)
E/e <15
(n  177)
E/e >15
(n  73) p Value
Timing of echocardiogram* 1.6  1.6 1.7  1.5 1.5  1.6 0.23
LVEF (%) 48  13 50  12 42  14 0.001
40% 178 (71%) 141 (80%) 37 (51%)
40% 72 (29%) 36 (20%) 36 (49%) 0.001
LV end-diastolic dimension (mm) 50  5 50  5 51  7 0.42
LV end-systolic dimension (mm) 37  9 35  8 41  9 0.01
Wall motion score index 1.6  0.4 1.5  0.4 1.8  0.4 0.001
Peak E-wave velocity (m/s) 0.8  0.2 0.7  0.2 1.0  0.2 0.001
Peak A-wave velocity (m/s) 0.8  0.2 0.7  0.2 0.8  0.3 0.06
Pulmonary vein systolic/diastolic ratio 1.3  1.1 1.4  1.2 1.0  0.5 0.001
E/A ratio 1.2  0.6 1.1  0.4 1.5  0.9 0.001
Deceleration time† (ms) 201  52 206  45 188  65 0.001
140 21 (9%) 6 (4%) 15 (22%)
140 219 (91%) 165 (96%) 54 (79%) 0.001
Mitral annulus e (cm/s) 6.51  2.21 7.27  2.09 4.67  1.13 0.001
E/e 13.8  6.8 10.5  2.8 22.0  6.8 0.001
Moderate or severe MR‡ 34 (14%) 15 (9%) 19 (26%) 0.001
*Days after admission. †Deceleration time could be assessed in 240 patients (96%). ‡Mitral regurgitation could be graded in 242
patients (97%). Data are expressed as the mean value  SD or number (percentage) of patients.
DT  deceleration time; LV  left ventricular; LVEF  left ventricular ejection fraction; MR  mitral regurgitation.
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RESULTS
The study cohort consisted of 155 male (68%) and 95
female (32%) patients with a mean age of 68  13 years
(Table 1). Baseline echocardiograms were obtained 1.6 
1.6 days after admission. The echocardiographic character-
istics of the entire study cohort and of those patients with
E/e 15 and 15 are shown in Table 2.
Seventy-three patients (29%) had an E/e 15. These
patients were older and more commonly female (Table 1).
In addition, they more often had diabetes mellitus and a
history of MI and were more likely to present with clinical
evidence of LV failure, as determined by the Killip class on
admission. There were moderate correlations between the
E/e ratio and Killip class (r  0.43, p  0.001) and mitral
DT (r  0.3, p  0.001). The only independent clinical
predictor of an E/e ratio 15 was Killip class 2 on
admission (odds ratio 4.65, 95% confidence interval [CI]
2.59 to 8.34, p  0.001).
On echocardiography, patients with an E/e ratio 15
had worse systolic function (as determined by the EF and
WMSI) and a shorter DT (Table 2). They were also more
likely to have moderate or severe mitral regurgitation.
Predictors of outcome. Vital status data were obtained for
all subjects. During a median follow-up period of 13 months
(interquartile range 11 to 19), 29 patients (12%) died. The
majority of deaths (19/29 [66%]) occurred in patients with
an E/e ratio in the upper three deciles (corresponding to
those individuals with a ratio 15). Figure 2 displays
survival in patients dichotomized according to E/e 15,
confirming the excess mortality associated with an elevated
ratio (log-rank statistic 21.3, p  0.0001). Similar analyses
were also performed after stratifying patients on the basis of
their LVEF. An E/e ratio15 predicted decreased survival
both in patients with an EF 40% (n  178, log-rank
statistic 12.3, p  0.0005) and 40% (n  72, log-rank
statistic 3.93, p  0.048) (Fig. 3). When patients were
stratified on the basis of their DT, an E/e ratio 15 was a
powerful predictor of mortality in patients with a DT 140
ms (n 219, log-rank statistic 10.7, p 0.001). In patients
with a DT 140 ms (n  21), the prognostic utility of an
E/e ratio 15 did not attain statistical significance (log-
rank statistic 3.3, p  0.07). However, none of the six
patients with a DT 140 ms, but E/e 15, died during
follow-up, compared with 6 of the 15 with a DT 140 ms,
but E/e 15. An E/e ratio 15 also predicted survival,
regardless of whether the patient had ST-segment elevation
(n  120, log-rank statistic 18.46, p  0.0001) or non–ST-
segment elevation MI (n 130, log-rank statistic 5.51, p
0.02).
Univariate predictors of outcome are shown in Table 3. In
a stepwise multivariable model in which all univariate (p 
0.05) predictors of outcome were considered, the most
powerful independent prognostic indicator was an E/e ratio
15 (risk ratio [RR] 4.8, 95% CI 2.1 to 10.8, p  0.0002).
The other independent predictors were myocardial revascu-
larization during the index admission (RR 0.31, 95% CI
Figure 2. Kaplan-Meier plot demonstrating survival in patients classified according to an E/e ratio of 15 or 15.
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0.14 to 0.69, p  0.004) and the index MI being anterior
(RR 2.24, 95% CI 1.01 to 4.98, p  0.047).
The incremental value of an E/e ratio 15 is shown in
Figure 4. The addition of E/e 15 significantly improved
the prognostic utility of a model containing clinical variables
(age, Killip class 2 on admission, anterior MI, myocardial
Figure 3. Survival of patients with an E/e ratio of 15 or 15, stratified according to left ventricular ejection fraction: (A) patients with ejection fraction
40%; (B) patients with ejection fraction 40%.
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revascularization during admission) and conventional echo-
cardiographic indexes of LV systolic and diastolic function
(EF and DT).
Discharge medication and outcome. At hospital dis-
charge, there was no difference in the use of aspirin (65/68
vs. 169/174, p  0.69) and angiotensin-converting enzyme
inhibitors/angiotensin II antagonists (47/68 vs. 105/174, p
 0.24) in patients with E/e 15 and15, respectively. In
contrast, patients with an E/e 15 were more likely to be
discharged on diuretic therapy (31/68 vs. 22/174, p 
0.001) and less likely to be prescribed beta-blockers (51/68
vs. 153/174, p  0.02) and lipid-lowering drugs (44/68 vs.
142/174, p  0.007).
Discharge on diuretics was associated with an increased
risk of death (RR 3.8, 95% CI 1.6 to 8.9, p  0.003).
Conversely, patients discharged on lipid-lowering drugs
and/or beta-blockers were less likely to die during follow-up
(RR 0.3, 95% CI 0.1 to 0.6, p 0.002 and RR 0.4, 95% CI
0.1 to 0.9, p  0.03, respectively). Being discharged on
aspirin and/or angiotensin-converting enzyme inhibitors/
angiotensin II antagonists had no significant effect on
survival in this cohort.
In the 242 patients (97%) who survived to hospital
discharge, an E/e ratio 15 remained a powerful predictor
of death (RR 5.5, 95% CI 2.2 to 13.6, p  0.001). It
remained an independent predictor when entered into a
stepwise multivariate model that also included discharge on
diuretics, discharge on lipid-lowering drugs, and discharge
on beta-blockers (RR 3.7, 95% CI 1.4 to 9.3, p  0.006).
The other independent predictors in this model were
discharge on diuretics (RR 2.8, 95% CI 1.2 to 6.9, p 0.02)
or lipid-lowering drugs (RR 0.3, 95% CI 0.1 to 0.7, p 
0.006).
DISCUSSION
The principal finding of the current study was that the E/e
ratio was a powerful predictor of survival after acute MI. An
E/e ratio of 15 proved to be superior, in this respect, to
other clinical or echocardiographic features measured in this
study. Furthermore, it provided prognostic information
incremental to these parameters.
Table 3. Univariate Predictors of All-Cause Mortality
Characteristic
Survivors
(n  221)
Deceased
(n  29)
Risk Ratio
(95% CI) p Value
Age (yrs) 67.7  13.4 72.4  11.5 1.02 (0.99–1.05)† 0.16
Male gender 136 (62%) 19 (66%) 1.17 (0.54–2.52) 0.69
Anterior MI 89 (40%) 17 (59%) 1.93 (0.92–4.05) 0.08
ST-segment elevation MI 108 (49%) 12 (41%) 0.77 (0.37–1.60) 0.48
Multivessel disease* 104 (54%) 13 (57%) 1.13 (0.50–2.59) 0.76
PCI or CABG during index admission 160 (72%) 15 (52%) 0.45 (0.22–0.93) 0.03
Killip class 2 on admission 84 (38%) 19 (66%) 3.09 (1.43–6.65) 0.004
Diabetes mellitus 50 (23%) 6 (21%) 0.88 (0.36–2.15) 0.77
Hypertension 128 (58%) 14 (48%) 0.70 (0.34–1.45) 0.34
Previous MI 42 (19%) 8 (28%) 1.55 (0.68–3.49) 0.30
Current smoker 51 (23%) 6 (21%) 0.91 (0.37–2.23) 0.84
LVEF (%) 49.1  12.6 40.1  15.2 0.95 (0.93–0.98)‡ 0.0004
Wall motion score index 1.57  0.42 1.79  0.49 2.82 (1.28–6.22) 0.01
Deceleration time
140 ms 15 (7%) 6 (23%) 3.53 (1.41–8.81) 0.007
140 ms 199 (93%) 20 (76%) 0.28 (0.11–0.71) 0.007
Moderate or severe MR 26 (12%) 8 (29%) 2.7 (1.2–6.2) 0.02
Peak E-wave velocity (m/s) 0.80  0.23 0.89  0.30 3.59 (0.85–15.1)§ 0.08
Mitral annulus e (cm/s) 6.65  2.18 5.45  2.18 0.74 (0.61–0.91) 0.005
E/e 13.3  6.4 17.8  8.0 1.07 (1.03–1.10) 0.0005
E/e 15 54 (24%) 19 (66%) 5.06 (2.35–10.9) 0.0001
*Angiography was performed in 216 (86%) patients, of whom 193 survived and 23 died during follow-up. †Risk ratio per year. ‡Risk ratio per 1% increase in ejection fraction.
§Risk ratio per 1 m/s increase in mitral peak E-wave velocity. Risk ratio per 1 cm/s increase in mitral annulus e velocity. Data are expressed as the mean value  SD or number
(percentage) patients.
Abbreviations as in Tables 1 and 2.
Figure 4. Incremental value of an E/e ratio 15 in predicting all-cause
mortality. The addition of left ventricular ejection fraction (LVEF),
deceleration time (DT), and E/e resulted in significant incremental
improvements in the predictive value of a model including clinical variables
(age, Killip class 2 on admission, anterior myocardial infarction, and
myocardial revascularization during the index admission): chi-square 
20.8 with 4 degrees of freedom for clinical factors; chi-sqaure  28.8 with
5 degrees of freedom for clinical factors plus LVEF; chi-square  33.2
with 6 degrees of freedom for clinical factors plus LVEF plus DT 140
ms; and chi-square  43.0 with 7 degrees of freedom for clinical factors
plus LVEF plus DT 140 ms plus an E/e ratio 15.
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Left ventricular filling pressure and survival after acute
MI. Elevated PCWP is associated with a higher mortality
rate after acute MI (20–22). There are several potential
explanations for this. Higher LV filling pressures are usually
indicative of larger infarcts with more severe systolic dys-
function (1,23–26). In addition, LV pressure overload
predisposes to ventricular remodeling, neurohormonal acti-
vation, and increased excitability (4,27,28), all of which
would be expected to adversely affect the outcome.
Despite its prognostic value, the measurement of PCWP
has obvious drawbacks (29–33). In contrast, Doppler echo-
cardiographic assessment of transmitral flow provides a
noninvasive means of identifying patients with elevated left
atrial pressures (34,35). Mild diastolic dysfunction is char-
acterized by impaired relaxation of the LV (without eleva-
tion of LV filling pressures). This means that the ventricle
takes longer to fill (lengthening the DT), with an increased
reliance on the atrial component of diastolic filling (reduc-
ing the E/A ratio). Worsening diastolic function is associ-
ated with rising left atrial pressures. This results in a higher
early diastolic gradient across the mitral valve, with rapid
equalization of the pressures in the left atrium and ventricle.
Initially, this normalizes the DT and mitral E/A ratio
(pseudonormalization), but ultimately the mitral E wave
becomes markedly predominant and the DT becomes very
abbreviated (35).
Advanced diastolic dysfunction is associated with an
adverse outcome after acute MI, with an abbreviated DT
being particularly predictive (2–6). The current data con-
firm the prognostic value of a short DT. In addition, they
corroborate the well-documented prognostic value of clini-
cal indicators of LV filling pressures, such as Killip class
(21).
Added value of E/e. The current study demonstrates that,
in the acute setting, elevated E/e is moderately correlated
with traditional transmitral Doppler evidence of elevated
LV filling pressures, but is a more powerful prognostic
indicator. This is in keeping with previous data demonstrat-
ing that E/e is better correlated with invasive measurement
of mLVEDP (7). E/e was also moderately correlated with
Killip class on admission but, once more, proved to be a
superior predictor of survival. Again, this might be expected
given the limited correlation between clinical features of
elevated LV filling pressures and invasive hemodynamics
(36,37), with the latter having prognostic superiority (37).
Transmitral diastolic flow velocities and DT correlate
well with LV filling pressure in patients with impaired LV
systolic function but are of limited value in patients with
preserved LV systolic function (7,38). In contrast, the E/e
ratio correlates well with filling pressure, even in patients
with a normal LVEF (7). In the current cohort, an E/e
ratio15 was a significant predictor of an adverse outcome,
regardless of LVEF (Fig. 3), the presence or absence of
ST-segment elevation, or drug therapy on hospital dis-
charge.
The E/e ratio was superior to conventional parameters of
LV systolic function, such as LVEF and WMSI, for
prediction of prognosis. However, it is important to recog-
nize that measurement of E/e provides complementary
prognostic data, with the maximum information obtained
by combining this with clinical, systolic, and conventional
diastolic parameters.
Study limitations. Not all patients presenting with acute
MI during the study period underwent echocardiography.
In addition, measurement of E/e was performed at the
discretion of the sonographer and physician performing
echocardiography. Nevertheless, the current cohort repre-
sents a consecutive series of patients in whom this measure-
ment was available. Thus, it seems unlikely that a selection
bias could have influenced the observed results, which may
affect the findings’ applicability to other populations. Con-
versely, the measurements were obtained by multiple ob-
servers working in a clinical environment, suggesting that
the findings may be widely applicable.
Like all currently utilized Doppler, clinical, and hemo-
dynamic indexes, the E/e ratio reflects an instantaneous
measure of LV filling pressures. These may change over the
course of the peri-infarct period, and a single measurement
may not convey maximal prognostic information.
Conclusions. The current data demonstrate that an E/e
ratio of 15 is a powerful predictor of decreased survival
after acute MI. The prognostic value of E/e was incremen-
tal to clinical factors and conventional echocardiographic
parameters of LV systolic and diastolic function. Measure-
ment of E/e may therefore assist in the risk stratification of
patients in this setting.
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